Development of Listerial Meningitis during Ciprofloxacin Treatment
Open Access
- 1 November 1999
- journal article
- case report
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 29 (5), 1340-1341
- https://doi.org/10.1086/313488
Abstract
Listeria monocytogenes is a leading cause of community-acquired acute meningitis [1]. Optimal treatment is still uncertain, and there are no prospective, controKeywords
This publication has 11 references indexed in Scilit:
- Central Nervous System Infection with Listeria monocytogenes : 33 Yearsʼ Experience at a General Hospital and Review of 776 Episodes from the LiteratureMedicine, 1998
- Clinafloxacin (CI 960) is Superior to Standard Therapeutics in the Treatment of Murine Listeriosis and SalmonellosisZentralblatt für Bakteriologie, 1997
- In-vitro activity of trovafloxacin against clinical bacterial isolates from patients with cancer.Journal of Antimicrobial Chemotherapy, 1997
- ListeriosisClinical Infectious Diseases, 1997
- Comparative activities of new fluoroquinolones, alone or in combination with amoxicillin, trimethoprim-sulfamethoxazole, or rifampin, against intracellular Listeria monocytogenesAntimicrobial Agents and Chemotherapy, 1997
- Acute Bacterial Meningitis in Adults -- A Review of 493 EpisodesNew England Journal of Medicine, 1993
- Comparison of the antibacterial efficacies of ampicillin and ciprofloxacin against experimental infections with Listeria monocytogenes in hydrocortisone-treated miceAntimicrobial Agents and Chemotherapy, 1992
- In vitro evaluation of WIN 57273, a new broad-spectrum fluoroquinoloneAntimicrobial Agents and Chemotherapy, 1990
- The influence of ciprofloxacin treatment in vivo on cell-mediated immunity to Listeria monocytogenesZentralblatt für Bakteriologie, Mikrobiologie und Hygiene. Series A: Medical Microbiology, Infectious Diseases, Virology, Parasitology, 1988
- In-vitro activity of newer quinolones against aerobic bacteriaJournal of Antimicrobial Chemotherapy, 1986